Back
IDEXX Laboratories Vs. Novartis AG Industry Stock Comparison
Sell
50
IDXX
IDEXX Laboratories
Last Price:
$417.92
Seasonality Move:
5.78%
Buy
71
NVSEF
Novartis AG
Last Price:
$116.60
Seasonality Move:
6.56%
Sell
50
IDEXX Laboratories (IDXX)
is a Sell
Is IDEXX Laboratories a Buy, Sell or Hold?
-
The current IDEXX Laboratories [IDXX] share price is $423.60. The Score for IDXX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
IDXX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $116.60. The Score for NVSEF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IDXX Stock Price Chart
What is IDEXX Laboratories's stock price today?
-
The IDEXX Laboratories share price today is $423.60Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IDXX is experiencing slight selling pressure.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $116.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.
IDXX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.2 | Sell |
| Relative Strength Index (14 RSI): | 44.84 | Sell |
| Chaikin Money Flow: | -241037 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (419.35 - 450.29) | Sell |
| Bollinger Bands (100): | (415.24 - 446.96) | Sell |
NVSEF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.84 | Buy |
| Relative Strength Index (14 RSI): | 61.26 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (107.1 - 113.78) | Buy |
| Bollinger Bands (100): | (98.55 - 109.41) | Buy |
IDXX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 418.81 | Buy |
| 20-day SMA: | 430.67 | Sell |
| 50-day SMA: | 436.1 | Sell |
| 200-day SMA: | 458.62 | Sell |
| 8-day EMA: | 421.96 | Buy |
| 20-day EMA: | 428.11 | Sell |
| 50-day EMA: | 433.56 | Sell |
| 200-day EMA: | 454.47 | Sell |
NVSEF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.96 | Buy |
| 20-day SMA: | 111.23 | Buy |
| 50-day SMA: | 106.01 | Buy |
| 200-day SMA: | 106.77 | Buy |
| 8-day EMA: | 112.31 | Buy |
| 20-day EMA: | 110.66 | Buy |
| 50-day EMA: | 107.55 | Buy |
| 200-day EMA: | 104.74 | Buy |
IDEXX Laboratories Earnings Growth & IDXX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.22 per share, an increase this year of $1.28 per share, and an increase next year of $1.63 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
IDEXX Laboratories Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novartis AG Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||